While GLP-1 drugs can result in 15-25% total body weight loss, surgery often achieves 25-35% or more, with higher rates of long-term maintenance and remission of related diseases
Gut microbiome studies of both LC (Yeoh et al., 2021) and CFS (Knig et al., 2021) report deficiencies in butyrate and GABA producing bacteria, e.g., Bacteroides (Strandwitz et al., 2018), Bifidobacterium dentium (Pokusaeva et al., 2017), and Lactobacillus brevium (Ko et al., 2013)
Hypoglycemia Patients with Type 2 Diabetes In a trial of adult patients with type 2 diabetes and BMI greater than or equal to 27 kg/m 2 for weight reduction, clinically significant hypoglycemia (defined as a plasma glucose less than 54 mg/dL) was reported in 6.2% of WEGOVY-treated patients versus 2.5% of placebo-treated patients
Related research guides Tirzepatide Research Peptide (Lyophilised, HPLC 99%) 60.00